Iqvia Holdings Inc (IQV) Stock Price, Quote & News

Company Profile

IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and associated implementation services; real world solutions...

Industry: Diagnostics & Research

Sector: Healthcare

Phone: 919 998 2000

Website: www.iqvia.com

Address:

2400 Ellis Road, Durham, United States

ripster47 Jun. 17 at 2:49 PM

$IQV | Morgan Stanley Downgrades IQVIA Holdings to Equalweight with $200 PT on AI Monetization Uncertainty Morgan Stanley stays cautious as limited near-term upside and AI-related overhang temper multiple expansion. 🔹 Follow @tenet_research for more analyst insights on other tickers.

0 · Reply

briefingcom Jun. 17 at 12:45 PM

$IQV: IQVIA downgraded to Equal Weight from Overweight at Morgan Stanley, tgt $200 https://www.briefing.com/calendars/updown?Filter=downgrades&utm_campaign=updown&utm_medium=social&utm_source=st&utm_content=link

0 · Reply

SuperGreenToday Jun. 3 at 7:26 AM

$IQV Share Price: $180.62 Contract Selected: Nov 20, 2026 $180 Calls Buy Zone: $16.41 – $20.27 Target Zone: $27.07 – $33.09 Potential Upside: 56% ROI Time to Expiration: 169 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

Serranito May. 31 at 3:29 PM

$IQV More info: https://onlytradersfans.com/threads/iqvia-holdings-analisis-tecnico.10944/

0 · Reply

AcceleratorModel May. 30 at 1:59 AM

$IQV missed it lol

0 · Reply

c049356 May. 27 at 11:15 PM

$TEM $IQV have they figured out how to license their shit to the LLMs and Models that NEED them to train on?

0 · Reply

BillionerOfKing May. 27 at 3:36 PM

$IQV Current Stock Price: $165.40 Contracts to trade: $165.0 IQV Jun 18 2026 Call Entry: $6.40 Exit: $12.52 ROI: 96% Hold ~26 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

CapitalMonk May. 25 at 10:32 PM

$IQV Price: $167.90 (-0.07%) Trend: Bearish Market Bias (7D): Sideways ⚖️ Expected Range: ±1.99% RSI: 58.8 | Momentum: Moderate Volume: -2.6% vs avg Volatility: 2.65% Support: $154.50 | Resistance: $182.70 Sourch: http://marketbaubles.com/

0 · Reply

CapitalMonk May. 21 at 10:58 PM

$IQV Price: $168.02 (-2.03%) Trend: Bearish Market Bias (7D): Bullish Bias 📈 Expected Range: ±1.86% RSI: 62.0 | Momentum: Strong Momentum Volume: -5.8% vs avg Volatility: 2.66% Support: $154.50 | Resistance: $182.70 Sourch: http://marketbaubles.com/

0 · Reply

StockConsultant May. 20 at 1:08 PM

$IQV IQVIA stock watch, strong rally off the low with a nice setup at 170.58 support area and possible future breakout at https://stockconsultant.com/?IQV

0 · Reply

StackAdapt Teams Up with IQVIA Digital's MediaOS to Power Healthcare Advertising

Jun 17, 2026, 12:30 PM EDT - 1 day ago

The Healthcare M&A Wave

ABT ALNY AMGN AMRX ANTX AZN BDX

2026-06-17T10:36:54.000Z - 1 day ago

Iqvia downgraded to Equal Weight from Overweight at Morgan Stanley

CRL

Jun 15, 2026, 9:00 AM EDT - 3 days ago

Wiley and IQVIA Release Cross-Sector Report on AI's Promise and Pressure Points Across Healthcare Value Chain

WLY

Jun 4, 2026, 10:51 AM EDT - 14 days ago

IQVIA Announces Pricing of Senior Notes

Jun 3, 2026, 9:20 AM EDT - 15 days ago

IQVIA Holdings Transcript: Jefferies Global Healthcare Conference 2026

2026-06-03T09:31:51.000Z - 15 days ago

Iqvia price target lowered to $210 from $240 at HSBC

Jun 3, 2026, 2:53 AM EDT - 15 days ago

IQVIA Announces Offering of Senior Notes

May 26, 2026, 4:15 PM EDT - 23 days ago

IQVIA CEO to Speak at Jefferies Global Healthcare Conference

2026-05-13T21:43:22.000Z - 5 weeks ago

Iqvia, Kexing expand strategic collaboration

May 13, 2026, 4:30 PM EDT - 5 weeks ago

IQVIA and Kexing Biopharm Expand Strategic Collaboration to Accelerate Global Biosimilar Development using AI-Enabled Capabilities

May 13, 2026, 1:40 PM EDT - 5 weeks ago

IQVIA Holdings Transcript: Bank of America Global Healthcare Conference 2026

2026-05-07T22:32:36.000Z - 6 weeks ago

Iqvia approves $2B increase to share repurchase authorization

May 7, 2026, 5:15 PM EDT - 6 weeks ago

IQVIA Board of Directors Approves $2 Billion Increase in Share Repurchase Authorization

2026-05-07T19:12:44.000Z - 6 weeks ago

Iqvia price target lowered to $225 from $240 at Morgan Stanley

May 6, 2026, 4:15 PM EDT - 6 weeks ago

IQVIA CFO to Speak at Bank of America Health Care Conference 2026

May 5, 2026, 9:00 AM EDT - 6 weeks ago

IQVIA Holdings Earnings Call Transcript: Q1 2026

May 5, 2026, 9:00 AM EDT - 6 weeks ago

IQVIA Holdings Earnings release: Q1 2026

May 5, 2026, 9:00 AM EDT - 6 weeks ago

IQVIA Holdings Slides: Q1 2026

May 5, 2026, 9:00 AM EDT - 6 weeks ago

IQVIA Holdings Quarterly report: Q1 2026

May 5, 2026, 7:00 AM EDT - 6 weeks ago

IQVIA Reports First-Quarter 2026 Results

Apr 15, 2026, 4:15 PM EDT - 2 months ago

IQVIA to Announce First-Quarter 2026 Results on May 5, 2026

2026-04-08T13:17:34.000Z - 2 months ago

Iqvia price target lowered to $185 from $225 at Evercore ISI

Mar 16, 2026, 4:30 PM EDT - 3 months ago

IQVIA Unveils IQVIA.ai, a Unified Agentic AI Platform Powered by NVIDIA to Improve Efficiency and Decision Making Across Life Sciences

Mar 12, 2026, 9:30 AM EDT - 3 months ago

IQVIA Holdings Transcript: Barclays 28th Annual Global Healthcare Conference

Mar 9, 2026, 9:20 AM EDT - 3 months ago

IQVIA Holdings Transcript: Leerink Global Healthcare Conference 2026

2026-03-09T09:50:09.000Z - 3 months ago

Iqvia upgraded to Buy from Hold at TD Cowen

2026-03-09T09:40:46.000Z - 3 months ago

Iqvia price target raised to $213 from $174 at TD Cowen

2026-03-06T11:25:41.000Z - 3 months ago

Iqvia upgraded to Overweight from Equal Weight at Barclays

2026-03-06T11:11:16.000Z - 3 months ago

Iqvia upgraded to Overweight from Equal Weight at Barclays

2026-03-03T10:25:11.000Z - 3 months ago

Iqvia initiated with an Outperform at RBC Capital

Mar 2, 2026, 4:30 PM EST - 3 months ago

IQVIA CFO to Speak at Barclays 28th Annual Global Healthcare Conference

Mar 2, 2026, 4:15 PM EST - 3 months ago

IQVIA CEO to Speak at Leerink Partners 2026 Global Healthcare Conference

Feb 27, 2026, 4:47 PM EST - 3 months ago

IQVIA Releases its 2025 Sustainability Report

Feb 27, 2026, 7:00 AM EST - 3 months ago

IQVIA Holdings Proxy statement: Proxy Filing

Feb 27, 2026, 7:00 AM EST - 3 months ago

IQVIA Holdings Proxy statement: Proxy Filing

Feb 26, 2026, 11:00 AM EST - 4 months ago

IQVIA Holdings Transcript: Citi’s 2026 Unplugged MedTech and Life Sciences Access Day

2026-02-25T12:36:22.000Z - 4 months ago

Iqvia to acquire certain discovery services assets from Charles River

CRL

Feb 25, 2026, 7:00 AM EST - 4 months ago

IQVIA Signs Agreement to Acquire Drug Discovery Assets from Charles River Laboratories, Expanding End-to-End Drug Discovery Capabilities

Feb 24, 2026, 9:01 AM EST - 4 months ago

10 stocks Wall Street expects to roar back after dropping at least 20% in 2026

APP BKNG COF CSGP KKR NOW ORCL

Feb 18, 2026, 4:15 PM EST - 4 months ago

IQVIA to Speak at Citi's 2026 Unplugged MedTech and Life Sciences Access Day

Feb 10, 2026, 8:00 AM EST - 4 months ago

IQVIA and Duke Clinical Research Institute Announce Strategic Collaboration to Advance Clinical Research in Obesity and Related Conditions

Feb 5, 2026, 9:07 AM EST - 4 months ago

IQVIA forecasts weak annual profit on higher interest expenses

Feb 5, 2026, 9:00 AM EST - 4 months ago

IQVIA Holdings Earnings Call Transcript: Q4 2025

Feb 5, 2026, 9:00 AM EST - 4 months ago

IQVIA Holdings Annual report: Q4 2025

Feb 5, 2026, 9:00 AM EST - 4 months ago

IQVIA Holdings Earnings release: Q4 2025

Feb 5, 2026, 9:00 AM EST - 4 months ago

IQVIA Holdings Slides: Q4 2025

Feb 5, 2026, 7:00 AM EST - 4 months ago

IQVIA Reports Fourth-Quarter and Full-Year 2025 Results; Issues Full-Year 2026 Guidance

Jan 29, 2026, 8:00 AM EST - 5 months ago

IQVIA and Boehringer Ingelheim announce strategic long-term global commercial data foundation transformation collaboration

Jan 22, 2026, 4:05 PM EST - 5 months ago

IQVIA Named to the Fortune® World's Most Admired Companies™ List, Ranked No. 1 in Its Sector for Fifth Consecutive Year

Jan 20, 2026, 4:45 PM EST - 5 months ago

IQVIA to Announce Fourth-Quarter and Full-Year 2025 Results on February 5, 2026

Dec 2, 2025, 8:00 AM EST - 7 months ago

IQVIA Announces Strategic Collaboration with AWS, Naming AWS as Preferred Agentic Cloud Provider to Power Next-Generation AI Platform

Nov 11, 2025, 12:30 PM EST - 7 months ago

IQVIA Holdings Transcript: UBS Global Healthcare Conference 2025

Nov 5, 2025, 4:15 PM EST - 8 months ago

Dr. William G. Kaelin Jr. joins IQVIA Board of Directors

Oct 28, 2025, 9:00 AM EDT - 8 months ago

IQVIA Holdings Earnings Call Transcript: Q3 2025

Oct 28, 2025, 9:00 AM EDT - 8 months ago

IQVIA Holdings Quarterly report: Q3 2025

Oct 28, 2025, 9:00 AM EDT - 8 months ago

IQVIA Holdings Earnings release: Q3 2025

Oct 28, 2025, 9:00 AM EDT - 8 months ago

IQVIA Holdings Slides: Q3 2025

Oct 28, 2025, 7:53 AM EDT - 8 months ago

IQVIA narrows annual profit forecast amid continued research contract cancellations

Oct 28, 2025, 7:00 AM EDT - 8 months ago

IQVIA Reports Third-Quarter 2025 Results

Oct 21, 2025, 4:15 PM EDT - 8 months ago

IQVIA CEO Ari Bousbib to Speak at UBS Global Healthcare Conference on November 11, 2025

Sep 30, 2025, 4:15 PM EDT - 9 months ago

IQVIA to Announce Third-Quarter 2025 Results on October 28, 2025

Sep 26, 2025, 9:40 AM EDT - 9 months ago

ILMN Stock vs. IQV Stock

ILMN

Sep 16, 2025, 8:00 AM EDT - 9 months ago

IQVIA Receives WCG Pinnacle Award for Excellence in Site Relationships

Sep 10, 2025, 8:00 AM EDT - 10 months ago

IQVIA Announces Launch of Clinical Trial Financial Suite, a Next-Generation Platform for Integrated Financial Management

Sep 2, 2025, 9:41 AM EDT - 10 months ago

IQVIA names Michael Fedock as financial chief

Sep 2, 2025, 9:00 AM EDT - 10 months ago

IQVIA Announces CFO Transition in Early 2026

Aug 28, 2025, 8:00 AM EDT - 10 months ago

IQVIA and Flagship Pioneering Announce Strategic Collaboration to Accelerate the Development of Breakthrough Life Sciences Companies

FHTX MRNA SANA

Aug 19, 2025, 12:00 PM EDT - 10 months ago

The Big 3: BLDR, IQV, LOW

BLDR LOW

Aug 18, 2025, 9:00 AM EDT - 10 months ago

IQVIA and Veeva Announce Long-term Clinical and Commercial Partnerships and Resolution of All Disputes

VEEV

Jul 22, 2025, 9:00 AM EDT - 11 months ago

IQVIA Holdings Earnings Call Transcript: Q2 2025

Jul 22, 2025, 9:00 AM EDT - 11 months ago

IQVIA Holdings Quarterly report: Q2 2025

Jul 22, 2025, 9:00 AM EDT - 11 months ago

IQVIA Holdings Earnings release: Q2 2025

Jul 22, 2025, 9:00 AM EDT - 11 months ago

IQVIA Holdings Slides: Q2 2025

Jul 22, 2025, 8:42 AM EDT - 11 months ago

IQVIA beats quarterly estimates on resilient demand for healthcare analytics

Jul 22, 2025, 7:00 AM EDT - 11 months ago

IQVIA Reports Second-Quarter 2025 Results

Jul 1, 2025, 7:00 AM EDT - 1 year ago

IQVIA to Announce Second-Quarter 2025 Results on July 22, 2025

Jun 16, 2025, 9:00 AM EDT - 1 year ago

IQVIA Health Research Space Wins 2025 MedTech Breakthrough Award for ‘Best Mobile App for Patient Engagement'

Jun 11, 2025, 7:00 AM EDT - 1 year ago

IQVIA Launches New AI Agents for Life Sciences and Healthcare

May 27, 2025, 7:00 AM EDT - 1 year ago

Rein Therapeutics Announces First Patient Dosed in RENEW Phase 2 Trial of LTI-03 in Patients with IPF

RNTX

May 16, 2025, 8:00 AM EDT - 1 year ago

IQVIA and SCRI Collaborate to Accelerate Global Oncology Trials

May 13, 2025, 5:20 PM EDT - 1 year ago

IQVIA Holdings Transcript: BofA Securities 2025 Healthcare Conference

May 7, 2025, 4:15 PM EDT - 1 year ago

IQVIA CFO Ron Bruehlman to speak at the Bank of America Annual Health Care Conference on May 13

May 6, 2025, 9:00 AM EDT - 1 year ago

IQVIA Holdings Earnings Call Transcript: Q1 2025

May 6, 2025, 9:00 AM EDT - 1 year ago

IQVIA Holdings Quarterly report: Q1 2025

May 6, 2025, 9:00 AM EDT - 1 year ago

IQVIA Holdings Earnings release: Q1 2025

May 6, 2025, 9:00 AM EDT - 1 year ago

IQVIA Holdings Slides: Q1 2025

May 6, 2025, 7:00 AM EDT - 1 year ago

IQVIA Reports First-Quarter 2025 Results

Apr 28, 2025, 9:00 AM EDT - 1 year ago

IQVIA celebrates Marie E. Lamont and Dr. Joanne Hackett, winners of Healthcare Businesswomen's Association Awards

Apr 23, 2025, 9:00 AM EDT - 1 year ago

IQVIA named a front-runner in generative AI innovation by global industry research and analysis firm

Apr 21, 2025, 4:15 PM EDT - 1 year ago

IQVIA to Announce First-Quarter 2025 Results on May 6, 2025

ripster47 Jun. 17 at 2:49 PM

0 · Reply

briefingcom Jun. 17 at 12:45 PM

0 · Reply

SuperGreenToday Jun. 3 at 7:26 AM

0 · Reply

Serranito May. 31 at 3:29 PM

$IQV More info: https://onlytradersfans.com/threads/iqvia-holdings-analisis-tecnico.10944/

0 · Reply

AcceleratorModel May. 30 at 1:59 AM

$IQV missed it lol

0 · Reply

c049356 May. 27 at 11:15 PM

$TEM $IQV have they figured out how to license their shit to the LLMs and Models that NEED them to train on?

0 · Reply

BillionerOfKing May. 27 at 3:36 PM

0 · Reply

CapitalMonk May. 25 at 10:32 PM

0 · Reply

CapitalMonk May. 21 at 10:58 PM

0 · Reply

StockConsultant May. 20 at 1:08 PM

$IQV IQVIA stock watch, strong rally off the low with a nice setup at 170.58 support area and possible future breakout at https://stockconsultant.com/?IQV

0 · Reply

MarketBeat May. 11 at 4:05 AM

https://marketbeat.com/a/8646233/ $IQV IQVIA Q1 Earnings Call Highlights

0 · Reply

Trading_up_portfolio May. 10 at 9:53 PM

Been thinks ab AI affects on healthcare and real estate as adoption continues over the next 3 years 🤔🤔 $LABU $XBI $IQV

0 · Reply

BillionerOfKing May. 8 at 5:17 AM

$IQV Current Stock Price: $178.69 Contracts to trade: $180.0 IQV May 15 2026 Call Entry: $3.60 Exit: $6.72 ROI: 87% Hold ~21 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

AXLFI_HQ May. 6 at 11:38 PM

$IQV Q1 2026 earnings reveal broad-based strength across technology, financial services, industrials, healthcare, and energy sectors with companies consistently beating expectations and raising guidance, signaling management confidence in earnings durability and accelerated capital returns. Learn more: https://axlfi.com/themes/228

0 · Reply

BillionerOfKing May. 6 at 10:55 PM

$IQV Current Stock Price: $176.39 Contracts to trade: $175.0 IQV May 15 2026 Call Entry: $4.40 Exit: $6.95 ROI: 58% Hold ~27 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

CapitalMonk May. 6 at 11:10 AM

$IQV Price: $176.42 (+9.62%) Trend: Bearish Market Bias (7D): Bearish Bias 📉 Expected Range: ±0.70% RSI: 48.6 | Momentum: Moderate Volume: +138.6% vs avg Volatility: 3.39% Support: $154.50 | Resistance: $180.98 Tools used: https://www.trade-ideas.com Code: INTERSTOCK25

0 · Reply

1986iamwallstreet May. 5 at 11:29 AM

$IQV 🩸🩸🩸🩸🩸

0 · Reply

StocktwitsEarnings May. 5 at 11:08 AM

$IQV Q1 '26 Earnings Results & Recap • Reported GAAP EPS of $1.63 up 14.79% YoY • Reported revenue of $4.15B up 8.41% YoY • IQVIA is reaffirming full-year 2026 revenue guidance between $17.15B and $17.35B and Adjusted EBITDA between $3.98B and $4.03B, while raising Adjusted Diluted EPS guidance to $12.65-$12.95.

0 · Reply

AcceleratorModel Apr. 2 at 6:11 AM

$IQV important level here— see it if holds before earnings

0 · Reply

RunnerSignals Mar. 24 at 8:38 PM

$FIG $IQV $JEF $CHWY $AG Top stock upgrades today in the BUZZ https://stocksrunner.com/news/2026-03-24-top-stock-upgrades-today-in-the-buzz

0 · Reply

HellenJune Mar. 13 at 12:52 PM

$IQV the middleman not needed in R&D. Labourious unwanted processes that inflate the price of medicines and delay the access to the market. The parasit of the Healtchare industry. They work could be completly replaced by AI at no cost

2 · Reply

Market Cap	29.90B
Revenue (ttm)	16.31B
Net Income (ttm)	1.36B
EPS (ttm)	N/A
PE Ratio	16.01
Forward PE	15.38
Profit Margin	8.34%
Debt to Equity Ratio	2.49

Volume	3,703,600
Avg Vol	1,668,244
Day's Range	N/A - N/A
Shares Out	166.90M
Stochastic %K	5%
Beta	1.21
Analysts	Strong Sell
Price Target	$225.45